Addus HomeCare Corporation (ADUS)
NASDAQ:ADUS
Want to see ADUS full AI Analyst Report?
ADUS Stock Chart & Stats
$94.32
-$0.15(-0.12%)
At close: 4:00 PM EST
$94.32
-$0.15(-0.12%)
Day’s Range― - ―
52-Week Range$89.76 - $124.44
Previous CloseN/A
Volume20.85K
Average Volume (3M)265.31K
Market Cap
$1.71B
Enterprise Value$1.75B
Total Cash (Recent Filing)$103.06M
Total Debt (Recent Filing)$138.74M
Price to Earnings (P/E)17.0
Beta0.39
Next Earnings
Aug 03, 2026EPS Estimate
1.69Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)5.41
Shares Outstanding18,664,776
10 Day Avg. Volume223,346
30 Day Avg. Volume265,307
Financial Highlights & Ratios
PEG Ratio1.04
Price to Book (P/B)1.83
Price to Sales (P/S)1.39
P/FCF Ratio19.09
Enterprise Value/Market Cap1.02
Enterprise Value/Revenue1.21
Enterprise Value/Gross Profit3.72
Enterprise Value/Ebitda10.97
Forecast
1Y Price Target
$130.00Price Target Upside37.83% Upside
Rating ConsensusStrong Buy
Number of Analyst Covering12
EPS Forecast (FY)6.98
Revenue Forecast (FY)$1.52B
Bulls Say, Bears Say
Bulls Say
Balance Sheet StrengthLow and falling leverage (debt-to-equity down to ~0.12 TTM), substantial cash on hand and large revolver availability provide durable financial flexibility. This supports acquisition cadence, absorbs reimbursement timing shocks, and reduces refinancing risk over the medium term.
Cash Generation & MarginsConsistently positive free cash flow (rising to ~$137M TTM) plus expanding operating and net margins indicate sustainable operating leverage. Reliable cash conversion funds capex, M&A and debt reduction, and supports investment in hiring/technology without depending on external financing.
Personal Care Market Position & M&AA dominant personal care franchise with healthy same-store growth and targeted add-on acquisitions builds local density and payor relationships. This scale in Medicaid-funded services creates durable demand, operational efficiencies and a repeatable M&A playbook that supports long-term revenue and margin expansion.
Bears Say
2025 Growth SlowdownA material deceleration in organic growth in 2025 signals normalization risks: without consistent organic momentum, the company may need higher acquisition activity or state rate increases to sustain growth. That reliance can compress returns and increase execution risk over the medium term.
Underperforming Service LinesDeclines in home health, a complementary skilled-services offering, reduce diversification and weaken the company’s ability to provide a full continuum of care. Persistent softness constrains cross-selling, limits higher-reimbursement mix upside, and heightens vulnerability to payor mix shifts.
Receivables & Cash Conversion VolatilityElevated and volatile DSOs together with periods where operating cash flow lags net income increase working-capital needs and strain liquidity. Over time this raises funding costs, complicates integration of acquisitions, and magnifies exposure to state payment-cycle disruptions.
Addus Homecare News
ADUS FAQ
What was Addus HomeCare Corporation’s price range in the past 12 months?
Addus HomeCare Corporation lowest stock price was $89.76 and its highest was $124.44 in the past 12 months.
What is Addus HomeCare Corporation’s market cap?
Addus HomeCare Corporation’s market cap is $1.71B.
When is Addus HomeCare Corporation’s upcoming earnings report date?
Addus HomeCare Corporation’s upcoming earnings report date is Aug 03, 2026 which is in 64 days.
How were Addus HomeCare Corporation’s earnings last quarter?
Addus HomeCare Corporation released its earnings results on May 04, 2026. The company reported $1.62 earnings per share for the quarter, beating the consensus estimate of $1.545 by $0.075.
Is Addus HomeCare Corporation overvalued?
According to Wall Street analysts Addus HomeCare Corporation’s price is currently Undervalued.
Does Addus HomeCare Corporation pay dividends?
Addus HomeCare Corporation does not currently pay dividends.
What is Addus HomeCare Corporation’s EPS estimate?
Addus HomeCare Corporation’s EPS estimate is 1.69.
How many shares outstanding does Addus HomeCare Corporation have?
Addus HomeCare Corporation has 18,664,776 shares outstanding.
What happened to Addus HomeCare Corporation’s price movement after its last earnings report?
Addus HomeCare Corporation reported an EPS of $1.62 in its last earnings report, beating expectations of $1.545. Following the earnings report the stock price went down -1.678%.
Which hedge fund is a major shareholder of Addus HomeCare Corporation?
Currently, no hedge funds are holding shares in ADUS
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Addus Homecare Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Strong Buy
Average Price Target:
$130.00 (37.83% Upside)
$130.00 (37.83% Upside)
Blogger Sentiment
Bullish
ADUS Sentiment 70%
Sector Average ―
Sector Average ―
Hedge Fund Trend
Decreased
By 10.4K Shares
Last Quarter.
Last Quarter.
Insider Transactions
Sold Shares
Worth $46.5K over
the Last 3 Months
the Last 3 Months
Crowd Wisdom
Very Negative
Last 7 Days ▼ 1.3%
Last 30 Days ▼ 5.6%
Last 30 Days ▼ 5.6%
Technicals
SMA
Negative
20 days / 200 days
Momentum
-18.96%
12-Months-Change
Fundamentals
Return on Equity
9.34%
Trailing 12-Months
Asset Growth
2.00%
Trailing 12-Months
Company Description
Addus HomeCare Corporation
Addus HomeCare Corporation, together with its subsidiaries, provides personal care services to elderly, chronically ill, disabled persons, and individuals who are at risk of hospitalization or institutionalization in the United States. It operates through three segments: Personal Care, Hospice, and Home Health. The Personal Care segment provides non-medical assistance with activities of daily living. This segment offers services that include assistance with bathing, grooming, oral care, feeding and dressing, medication reminders, meal planning and preparation, housekeeping, and transportation services. The Hospice segment provides palliative nursing care, social work, spiritual counseling, homemaker, and bereavement counseling services for people who are terminally ill, as well as related services for their families. The Home Health segment offers skilled nursing and physical, occupational, and speech therapy for the individuals who requires assistance during an illness or after hospitalization. The company's payor clients include federal, state, and local governmental agencies; managed care organizations; commercial insurers; and private individuals. As of December 31, 2021, the company served consumers through 206 offices located in 22 states. Addus HomeCare Corporation was founded in 1979 and is based in Frisco, Texas.
ADUS Company Deck
ADUS Earnings Call
Q1 2026
0:00 / 0:00
Earnings Call Sentiment|Positive
The call presented a broadly positive operational and financial picture: solid top-line growth (+7.7% revenue), meaningful EPS and adjusted EBITDA improvements, strong operating cash flow ($52.4M) and a strengthened balance sheet with reduced bank debt and sizable revolver availability. Personal Care and Hospice were key growth drivers (Personal Care same-store +6.5%; Hospice ADC +8.2%). Management also highlighted progress on productivity (caregiver app), hiring, and targeted M&A (entry into Indiana). Challenges noted include a weather-driven $1.5M revenue hit, elevated DSOs (timing-driven), a YoY decline in home health revenue, and a reversion in hospice revenue-per-day dynamics. Overall, positives (multiple strong metrics, cash flow and M&A runway, operating improvements) outweigh the contained challenges and one-time items.View all ADUS earnings summariesADUS Stock 12 Month Forecast
Average Price Target
$130.00
▲(37.83% Upside)
Technical Analysis
National Healthcare
―
Select Medical
―
US Physical Therapy
―
Pennant Group
―
Aveanna Healthcare Holdings
―
Ownership Overview
2.82% Insiders
36.51% Mutual Funds
34.14% Other Institutional Investors
4.39% Public Companies and
Individual Investors